Z. F. Cuylan Et Al. , "Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7, pp.1284-1293, 2018
Cuylan, Z. F. Et Al. 2018. Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7 , 1284-1293.
Cuylan, Z. F., Meydanli, M. M., Sari, M. E., Akbayir, O., Celik, H., Dede, M., ... Sahin, H.(2018). Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7, 1284-1293.
Cuylan, Zeliha Et Al. "Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7, 1284-1293, 2018
Cuylan, Zeliha F. Et Al. "Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7, pp.1284-1293, 2018
Cuylan, Z. F. Et Al. (2018) . "Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.44, no.7, pp.1284-1293.
@article{article, author={Zeliha F. Cuylan Et Al. }, title={Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy}, journal={JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH}, year=2018, pages={1284-1293} }